These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1936894

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP, Dimitriadis E, Allen T, Dunlop ME, Cooper M, Larkins RG.
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [Abstract] [Full Text] [Related]

  • 6. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A, Ku L, Cohen MP.
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [Abstract] [Full Text] [Related]

  • 7. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies.
    Kassab JP, Guillot R, Andre J, Claperon N, Bellon G, Feldmann G, Peyroux J, Sternberg M.
    Biochem Pharmacol; 1994 Aug 30; 48(5):1003-8. PubMed ID: 8093087
    [Abstract] [Full Text] [Related]

  • 8. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
    Cohen MP.
    Metabolism; 1986 Apr 30; 35(4 Suppl 1):55-9. PubMed ID: 3007926
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG, Pugliese G, LaRose LS, Faller AM, Chang K, Province MA, Williamson JR.
    J Diabet Complications; 1991 Apr 30; 5(4):230-7. PubMed ID: 1779018
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
    Cohen MP, Klepser H.
    Diabetes; 1988 May 30; 37(5):558-62. PubMed ID: 2834250
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH, Ross IS.
    Br J Exp Pathol; 1988 Oct 30; 69(5):697-702. PubMed ID: 3143396
    [Abstract] [Full Text] [Related]

  • 19. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
    Cohen MP, Klepser H, Wu VY.
    Diabetes; 1988 Oct 30; 37(10):1324-7. PubMed ID: 2970980
    [Abstract] [Full Text] [Related]

  • 20. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
    Osterby R, Gundersen HJ.
    J Diabet Complications; 1989 Oct 30; 3(3):149-53. PubMed ID: 2528558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.